2/24
07:00 am
msle
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Low
Report
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
2/18
07:00 am
msle
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
Low
Report
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
2/17
07:00 am
msle
Satellos to Participate in Upcoming Investor Conferences
Low
Report
Satellos to Participate in Upcoming Investor Conferences
2/12
06:38 pm
msle
Satellos Bioscience (NASDAQ:MSLE) is now covered by analysts at
Weiss Ratings. They set a "sell (d-)" rating on the stock.
Low
Report
Satellos Bioscience (NASDAQ:MSLE) is now covered by analysts at
Weiss Ratings. They set a "sell (d-)" rating on the stock.
2/12
07:00 am
msle
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
Medium
Report
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
2/12
06:37 am
msle
Satellos Bioscience (NASDAQ:MSLE) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Satellos Bioscience (NASDAQ:MSLE) was upgraded by analysts at Zacks Research to a "hold" rating.
2/10
07:00 am
msle
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Medium
Report
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
2/9
05:48 pm
msle
Satellos Closes US$57.2 Million Public Offering in Canada and the United States [Yahoo! Finance]
Medium
Report
Satellos Closes US$57.2 Million Public Offering in Canada and the United States [Yahoo! Finance]
2/9
05:00 pm
msle
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
Low
Report
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
2/6
08:30 am
msle
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
Medium
Report
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States